Past, present & future scenario of thalassaemic care & control in India

Indian Journal of Medical Research

Volumn 134, Issue 10, 2011, Pages 507-521

  Verma, Ishwar C ^a   Saxena, Renu ^a   Kohli, Sudha ^a  

^a SIR GANGA RAM HOSPITAL   (India)

Author keywords

Blood transfusion; Bone marrow transplantation; Carrier screening; Chelation; Control; Cord blood storage; Prenatal diagnosis; Prevention; Thalassaemia care

Indexed keywords

ALPHA GLOBIN; BETA GLOBIN; DEFERASIROX; DEFERIPRONE; DEFEROXAMINE MESYLATE; HEMOGLOBIN E; HYDROXYUREA; ZOLEDRONIC ACID;

AGRANULOCYTOSIS; ALLELE; ARTHRALGIA; BETA THALASSEMIA; BLOOD DONOR; BLOOD TRANSFUSION; BONE DENSITY; BONE MARROW TRANSPLANTATION; CHELATION THERAPY; CODON; CORD BLOOD STEM CELL TRANSPLANTATION; COST EFFECTIVENESS ANALYSIS; DENATURING GRADIENT GEL ELECTROPHORESIS; DISEASE CARRIER; DNA POLYMORPHISM; DRUG COST; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; ERYTHROCYTE FRAGILITY; FINANCIAL MANAGEMENT; FRAMESHIFT MUTATION; GASTROINTESTINAL SYMPTOM; GENE INTERACTION; GROWTH; HAPLOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOSIDEROSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INDIA; IRON DEFICIENCY; IRON OVERLOAD; MARITAL THERAPY; PREGNANT WOMAN; PRENATAL DIAGNOSIS; PRENATAL SCREENING; REVIEW; SIDE EFFECT; SINGLE STRAND CONFORMATION POLYMORPHISM; SKIN PIGMENTATION; THALASSEMIA; THALASSEMIA MAJOR; THALASSEMIA MINOR; TREATMENT RESPONSE; VOCATIONAL EDUCATION; WHEAT;

BENZOIC ACIDS; BLOOD TRANSFUSION; FEMALE; HETEROZYGOTE DETECTION; HUMANS; INDIA; MALE; PREIMPLANTATION DIAGNOSIS; PRENATAL DIAGNOSIS; PYRIDONES; THALASSEMIA; TRIAZOLES;

EID: 80455168753     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Review

References (135)

1. Cooley TB, Lee P. Series of cases of splenomegaly in children with anemia and peculiar bone changes. Tr Am Pediatr Soc 1925; 37: 19.
2. Mukherji, M. Cooley's anaemia (erythroblastic or Mediterranean anaemia). Indian J Pediatr 1938; 5: 1-7.
3. Coelho C. Erythroblastic anemia- Cooley's anemia. Med Bull Bombay 1939; 7: 291-3.
4. Napier LE, Shorten JA, Das Gupta CR. Cooley's erythrolblastic anaemia. Indian NI Gaz 1939; 74: 660-4.
5. Patel ND, Bhende YM. Erythroblastic anaemia with kyphosis and cirrhosis of liver. Indian J Pediatr 1939; 6: 217-22.
6. Malhotra RP, Chhuttani PN. Case of Cooley's anaemia. Indian Med Gaz 1944; 79: 198-9.
7. Chaudhuri KC. Erythroblastic anaemia of Cooley. Indian J Pediatr 1947; 14: 76-80.
8. Ghai OP, Varma KP, Taneja PN. Hemoglobinopathies in north India - 1. Hemoglobin D trait and hemoglobin D thalassemia. Indian J Child Health 1961; 10: 334-41.
9. Sharma RS, Parekh JG, Shah KM. Hemoglobinopathies in Western India. J Assoc Physicians India 1963; 11: 969-73.
10. Sinha KP, Prasad LS, Saran A. Hemoglobinopathy in Bihar. J Indian Med Assoc 1964; 42: 219-23.
11. Praharaj KC, Mohanta KD, Kar RS, Swain U, Nanda BK. Haemoglobinopathy in Orissa. Indian Pediatr 1969; 6: 533-7.
12. Laxman S, Mathur YC, Chandra H, Reddi YR. Haemoglobinopathy in Andhra Pradesh. Indian J Pediatr 1971; 38: 365-7.
13. Dash S, Dash RJ. Spectrum of haemolytic anaemias in Punjab, North India. Trop Geogr Med 1980; 32: 312-6.
14. Jain RC. Prevalence of abnormal haemoglobin, thalassaemia & G-6 PD deficiency among the hospital population of Udaipur (Rajasthan). Indian J Med Res 1984; 80: 332-8.
15. Chatterjee JB, Saha AK, Ray RN, Ghosh SK. Hemoglobin E-thalassemia disease. Indian J Med Sci 1957; 11: 553-64.
16. Naik SK, Kothari BV, Jhaveri CL, Sukumaran PK, Sanghvi LD. Fatal hemolytic anemia presumably due to the combination of sickle cell and thalassemia gene; case report. Indian J Med Sci 1957; 11: 244-9.
17. Swarup S, Ghosh SK, Chatterjee JB. Haemoglobins E and K and thalassemia in an Indian family with evidence of interaction between haemoglobin E and thalassaemia. J Indian Med Assoc 1966; 46: 587-90.
18. Sukumaran PK, Merchant SM, Desai MP, Wiltshire BG, Lehmann H. Haemoglobin Q India (alpha 64(E13) aspartic acid histidine) associated with beta-thalassemia observed in three Sindhi families. J Med Genet 1972; 9: 436-42.
19. Ajmani M, Sharma A, Talukder G, Bhattacharyya DK. Genetic interaction of beta-thalassaemia (Hb βT-) & haemoglobin E (Hb βE) in populations of Eastern India. Indian J Exp Biol 1977; 15: 455-7.
20. Kumar S, Rana M, Handoo A, Saxena R, Verma IC, Bhargava M, et al. Case report of HbC/β0-thalassemia from India. Int J Lab Hematol 2007; 29: 381-5.
21. Chatterjee JB. Haemoglobinopathies, glucose-6-phosphate dehydrogenase deficiency and allied problems in the Indian subcontinent. Bull World Health Organ 1966; 35: 837-56.
22. Kazazian HH Jr, Orkin SH, Antonarakis SE, Sexton JP, Boehm CD, Goff SC, et al. Molecular characterization of seven beta-thalassemia mutations in Asian Indians. EMBO J 1984; 3: 593-6.
23. Wood S, Daya M, Allanson JE, Kirby L, Coupland R, Gray GR. Partial deletion of the beta-globin gene: a common beta-thalassaemia allele in Asian Indians. Can J Genet Cytol 1984; 26: 296-301.
24. Thein SL, Old JM, Wainscoat JS, Petrou M, Modell B, Weatherall DJ. Population and genetic studies suggest a single origin for the Indian deletion beta thalassaemia. Br J Haematol 1984; 57: 271-8.
25. Old JM, Petrou M, Modell B, Weatherall DJ. Feasibility of antenatal diagnosis of β thalassaemia by DNA polymorphisms in Asian Indian and Cypriot populations. Br J Haematol 1984; 57: 255-63.
26. Thein SL, Hesketh C, Wallace RB, Weatherall DJ. The molecular basis of thalassaemia major and thalassaemia intermedia in Asian Indians: application to prenatal diagnosis. Br J Haematol 1988; 70: 225-31.
27. Old JM, Varawalla NY, Weatherall DJ. Rapid detection and prenatal diagnosis of β-thalassaemia: studies in Indian and Cypriot populations in the UK. Lancet 1990; 336: 834-7.
28. Varawalla NY, Old JM, Sarkar R, Venkatesan R, Weatherall DJ. The spectrum of β-thalassaemia mutations on the Indian subcontinent: the basis for prenatal diagnosis. Br J Haematol 1991; 78: 242-7.
29. Verma IC, Saxena R, Thomas E, Jain PK. Regional distribution of β-thalassemia mutations in India. Hum Genet 1997; 100: 109-13.
30. Vaz FE, Thakur CB, Banerjee MK, Gangal SG. Distribution of β-thalassemia mutations in the Indian population referred to a diagnostic center. Hemoglobin 2000; 24: 181-94.
31. Colah R, Gorakshakar A, Nadkarni A, Phanasgaonkar S, Surve R, Sawant P, et al. Regional heterogeneity of β-thalassemia mutations in the multi ethnic Indian population. Blood Cells Mol Dis 2009; 42: 241-6.
32. Bandyopadhyay A, Bandyopadhyay S, Basak J, Mondal BC, Sarkar AA, Majumdar S, et al. Profile of β-thalassemia in eastern India and its prenatal diagnosis. Prenat Diagn 2004; 24: 992-6.
33. Venkatesan R, Sarkar R, Old JM. β-Thalassaemia mutations and their linkage to β-haplotypes in Tamil Nadu in southern India. Clin Genet 1992; 42: 251-6.
34. Agarwal S, Naveed M, Gupta UR, Kishore P, Agarwal SS. Characterization of β-thalassaemia mutations in 57 β-thalassaemia families seen at Lucknow. Indian J Med Res 1994; 100: 106-10.
35. Garewal G, Fearon CW, Warren TC, Marwaha N, Marwaha RK, Mahadik C, et al. The molecular basis of β thalassaemia in Punjabi and Maharashtran Indians includes a multilocus aetiology involving triplicated alpha-globin loci. Br J Haematol 1994; 86: 372-6.
36. Shaji RV, Edison ES, Poonkuzhali B, Srivastava A, Chandy M. Rapid detection of β-globin gene mutations and polymorphisms by temporal temperature gradient gel electrophoresis. Clin Chem 2003; 49: 777-81.
37. Edison ES, Shaji RV, Devi SG, Moses A, Viswabandhya A, Mathews V, et al. Analysis of β globin mutations in the Indian population: presence of rare and novel mutations and region-wise heterogeneity. Clin Genet 2008; 73: 331-7.
38. Nadkarni A, Pawar A, Mudera VC, Mohanty D, Colah R. Clinical heterogeneity of silent-gene β-thalassemia among Indians. Ann Hematol 1995; 70: 61-4.
39. Old JM, Khan SN, Verma I, Fucharoen S, Kleanthous M, Ioannou P, et al. A multi-center study in order to further define the molecular basis of β-thalassemia in Thailand, Pakistan, Sri Lanka, Mauritius, Syria, and India, and to develop a simple molecular diagnostic strategy by amplification refractory mutation system-polymerase chain reaction. Hemoglobin 2001; 25: 397-407.
40. Sinha S, Black ML, Agarwal S, Colah R, Das R, Ryan K, et al. Profiling β-thalassaemia mutations in India at state and regional levels: implications for genetic education, screening and counselling programmes. Hugo J 2009; 3: 51-62.
41. Gorakshakar AC, Das MK, Phanasgaokar SP, Nadkarni AH, Colah RB, Mohanty D. Origin of the codon 47 (+A) β-thalassaemia mutation among the Nicobarese of the Andaman and Nicobar islands in India. Br J Haematol 2007; 139: 345-6.
42. Sinha S, Black ML, Agarwal S, Das R, Bittles AH, Bellgard M. ThalInd, a β-thalassemia and hemoglobinopathies database for India: defining a model country-specific and disease-centric bioinformatics resource. Hum Mutat 2011; 32: 887-93.
43. Kulozik AE, Kar BC, Serjeant GR, Serjeant BE, Weatherall DJ. The molecular basis of alpha thalassemia in India. Its interaction with the sickle cell gene. Blood 1988; 71: 467-72.
44. Nadkarni AH, Gorakshakar AC, Mohanty D, Colah RB. Alpha genotyping in a heterogeneous Indian population. Am J Hematol 1996; 53: 149-50.
45. Panigrahi I, Marwaha RK, Kulkarni K. The expanding spectrum of thalassemia intermedia. Hematology 2009; 14: 311-4.
46. Verma IC, Kleanthous M, Saxena R, Fucharoen S, Winichagoon P, Raizuddin S, et al. Multicenter study of the molecular basis of thalassemia intermedia in different ethnic populations. Hemoglobin 2007; 31: 439-52.
47. Oberoi S, Das R, Panigrahi I, Kaur J, Marwaha RK. Xmn1- (G) γ polymorphism and clinical predictors of severity of disease in β-thalassemia intermedia. Pediatr Blood Cancer 2011; 57: 1025-8.
48. Sangani B, Sukumaran PK, Mahadik C, Yagnik H, Telang S, Vas F, et al. Thalassemia in Bombay: the role of medical genetics in developing countries. Bull World Health Organ 1990; 68: 75-81.
49. Khurana A, Katyal S, Marwaha RK. Psychosocial burden in thalassemia. Indian J Pediatr 2006; 73: 877-80.
50. Khairkar P, Malhotra S, Marwaha RK. Growing up with the families of β-thalassaemia major using an accelerated longitudinal design. Indian J Med Res 2010; 132: 428-37.
51. Choudhry VP, Desai N, Pati HP, Nanu A. Current management of homozygous beta thalassemia. Indian Pediatr 1991; 28: 1221-9.
52. Lokeshwar MR. Progress in the management of thalassemia. Indian Pediatr 2006; 43: 503-6.
53. Dubey AP, Parakh A, Dublish S. Current trends in the management of beta thalassemia. Indian J Pediatr 2008; 75: 739-43.
54. Agarwal MB. Advances in management of thalassemia. Indian J Pediatr 2009; 76: 177-84.
55. Marwaha N. Whole blood and component use in resource poor settings. Biologicals 2010; 38: 68-71.
56. http://www.indianredcross.org, accessed on August 5, 2011.
57. Bhattacharya N, Mukherijee K, Chettri MK, Banerjee T, Mani U, Bhattacharya S. A study report of 174 units of placental umbilical cord whole blood transfusion in 62 patients as a rich source of fetal hemoglobin supply in different indications of blood transfusion. Clin Exp Obstet Gynecol 2001; 28: 47-52.
58. Ramani KV, Mavalankar D, Govil D. Management of blood transfusion services in India: An illustrative study of Maharashtra and Gujarat States, W.P. No. 2007-03-09, March 2007. Ahmedabad: Indian Institute of Management; 2007.
59. De M, Banerjee D, Chandra S, Bhattacharya DK. HBV & HIV seropositivity in multi-transfused haemophilics & thalassaemics in eastern India. Indian J Med Res 1990; 91: 63-6.
60. Choudhry VP, Acharya SK. Hepatitis B, C & D viral markers in multitransfused thalassemic children: long-term complications and present management. Indian J Pediatr 1995; 62: 655-68.
61. Sur D, Chakraborty AK, Mukhopadhyay SP. Dr. P. C. Sen Memorial Award Paper. A study of HIV infection in thalassaemia patients of rural Bengal. Indian J Public Health 1998; 42: 81-7.
62. Marwaha RK, Bansal D, Sharma S, Kumar S, Trehan A, Duseja A, et al. Seroprevalence of hepatitis C and B virus in multiply transfused beta-thalassemics: results from a thalassemic day care unit in north India. Vox Sang 2003; 85: 119-20.
63. Chaudhury N. Need to change present regulatory framework for blood banks in India. Asian J Trans Med 2011; 5: 1-2.
64. Kontoghiorghes GJ. The proceedings of the 17th International Conference on Chelation: application of effective chelation therapies in iron loading and non iron loading conditions, and the gap in the prevention and treatment policies on thalassemia between developed and developing countries. Hemoglobin 2009; 33: 283-6.
65. Agarwal MB, Gupte SS, Viswanathan C, Vasandani D, Ramanathan J, Desai N, et al. Long-term assessment of efficacy and safety of L1, an oral iron chelator, in transfusion dependent thalassaemia: Indian trial. Br J Haematol 1992; 82: 460-6.
66. Agarwal MB. Oral iron chelation: a review with special emphasis on Indian work on deferiprone (L1). Indian J Pediatr 1993; 60: 509-16.
67. Adhikari D, Roy TB, Biswas A, Chakraborty ML, Bhattacharya B, Maitra TK, et al. Efficacy and safety of oral iron chelating agent deferiprone in beta-thalassemia and hemoglobin E-beta thalassemia. Indian Pediatr 1995; 32: 855-61.
68. Choudhry VP. Oral deferiprone--controversies on its efficacy and safety. Indian J Pediatr 1998; 65: 825-8.
69. Gomber S, Saxena R, Madan N. Comparative efficacy of desferrioxamine, deferiprone and in combination on iron chelation in thalassemic children. Indian Pediatr 2004; 41: 21-7.
70. Goel H, Girisha KM, Phadke SR. Long-term efficacy of oral deferiprone in management of iron overload in beta thalassemia major. Hematology 2008; 13: 77-82.
71. Dubey AP, Sudha S, Parakh A. Deferasirox: the new oral iron chelator. Indian Pediatr 2007; 44: 603-7.
72. Agarwal MB. Deferasirox: oral, once daily iron chelator - an expert opinion. Indian J Pediatr 2010; 77: 185-91.
73. Chandra J, Chaudhary H, Pemde H, Singh V, Dutta AK. Safety and efficacy of deferasirox in multitransfused Indian children with β-thalassaemia major. Ann Trop Paediatr 2011; 31: 47-51.
74. Marawaha RK, Bansal D, Kaur S, Trehan A. Wheat grass juice reduces transfusion requirement in patients with thalassemia major: a pilot study. Indian Pediatr 2004; 41: 716-20.
75. Choudhary DR, Naithani R, Panigrahi I, Kumar R, Mahapatra M, Pati HP, et al. Effect of wheat grass therapy on transfusion requirement in beta-thalassemia major. Indian J Pediatr 2009; 76: 375-6.
76. Singh K, Pannu MS, Singh P, Singh J. Effect of wheat grass tablets on the frequency of blood transfusions in thalassemia major. Indian J Pediatr 2010; 77: 90-1.
77. Choudhry VP, Lal A, Pati HP, Arya LS. Hematological responses to hydroxyurea therapy in multitransfused thalassemic children. Indian J Pediatr 1997; 64: 395-8.
78. Panigrahi I, Dixit A, Arora S, Kabra M, Mahapatra M, Choudhry VP, et al. Do alpha deletions influence hydroxyurea response in thalassemia intermedia? Hematology 2005; 10: 61-3.
79. Italia KY, Jijina FJ, Merchant R, Panjwani S, Nadkarni AH, Sawant PM, et al. Response to hydroxyurea in β-thalassemia major and intermedia: experience in western India. Clin Chim Acta 2009; 407: 10-5.
80. Raina A, Verma IC, Saxena R, Kaul D, Khanna VK. Relation of Xmn-1 polymorphism and five common Indian mutations of thalassaemia with phenotypic presentation in β-thalassaemia. J K Sci 2006; 8: 139-43.
81. Chandy M. Stem cell transplantation in India. Bone Marrow Transplant 2008; 42: S81-4.
82. Kumar R, Naithani R, Mishra P, Mahapatra M, Seth T, Dolai TK, et al. Allogeneic hematopoietic SCT performed in non-HEPA filter rooms: initial experience from a single center in India. Bone Marrow Transplant 2009; 43: 115-9.
83. Kanga U, Panigrahi A, Kumar S, Mehra NK. Asian Indian donor marrow registry: All India Institute of Medical Sciences experience. Transplant Proc 2007; 39: 719-20.
84. Suryanarayan D. Marrow donors on the rise, but they are not enough. DNA, Mumbai. May 12, 2010.
85. http://www.relicord.com, accessed on October 4, 2011.
86. http://www.bmdw.org/, accessed on August 5, 2011.
87. http://www.worldmarrow.org/, accessed on August 5, 2011.
88. Gomber S, Dewan P. Physical growth patterns and dental caries in thalassemia. Indian Pediatr 2006; 43: 1064-9.
89. Merchant RH, Shirodkar A, Ahmed J. Evaluation of growth, puberty and endocrine dysfunctions in relation to iron overload in multi transfused Indian thalassemia patients. Indian J Pediatr 2011; 78: 679-83.
90. George A, Bhaduri A, Choudhry VP. Development of secondary sex characteristics in multitransfused thalassemic children. Indian J Pediatr 1997; 64: 855-9.
91. Khairwa A, Chaudhary A, Jat KR. Assessment of glucose tolerance in multi-transfused adolescent and young adult patients with beta thalassemia. Indian J Pediatr 2011; 78: 1297-8.
92. Mamtani M, Kulkarni H. Bone recovery after zoledronate therapy in thalassemia-induced osteoporosis: a meta-analysis and systematic review. Osteoporos Int 2010; 21: 183-7.
93. Ginsberg G, Tulchinsky T, Filon D, Goldfarb A, Abramov L, Rachmilevitz EA. Cost benefit analysis of a national thalassemia prevention programme in Israel. J Med Screening 1998; 5: 120-6.
94. Guidelines for control of hemoglobin disorders. World Health Organization hereditary disease program. WHO/HDP/HB/gl/94.1. Geneva: WHO; 1994.
95. Cao A, Galanello R, Rosatelli MC. Prenatal diagnosis and screening of the haemoglobinopathies. Baillieres Clin Haematol 1998; 11: 215-38.
96. Verma IC, Choudhry VP, Jain PK. Prevention of thalassemia: a necessity in India. Indian J Pediatr 1992; 59: 649-54.
97. Angastiniotis MA, Model B. Prevention of thalassemia in Cyprus. Lancet 1981; 1: 369-70.
98. Angastiniotis MA, Kyriakidou S, Hadjiminas M. How thalassemia was controlled in Cyprus. World Health Forum 1986; 7: 291-7.
99. Stamatoyannopoulos G. Probelms of screening and counseling in the hemoglobinopathies. In: Motulsky AG, Lenz W, editors. Birth defects. Amsterdam: Excerpta Medica; 1974. p. 268-76.
100. Gamberini MR, Lucci M, Vullo C, Anderson B, Canella R, Barrai I. Reproductive behavior of families segregating for Cooley's anaemia before and after the availability of prenatal diagnosis. J Med Genet 1991; 28: 523-9.
101. Samavat A, Modell B. Iranian national thalassemia screening programme. BMJ 2004; 329: 1134-7.
102. Haddow JE. Couple screening to avoid thalassemia: successful in Iran and instructive for us all. J Med Screen 2005; 12: 55-6.
103. Karimi M, Jamalian N, Yarmohammadi H, Askarnejad A, Afrasiabi A, Hashemi A. Premarital screening for β-thalassaemia in Southern Iran:options for improving the programme J Med Screen 2007; 14: 62-6.
104. Zeesman S, Clow CL, Cartier L, Scriver CR. A private view of heterozygosity:eight year follow-up study on carriers of Tay - Sachs gene detected by high- school screening in Montreal. Am J Med Genet 1984; 18: 769-78.
105. Chattopadhyay S. 'Rakter dosh' - corrupting blood: The challenges of preventing thalassemia in Bengal, India. Soc Sci Med 2006; 63: 2661-73.
106. Tamhankar PM, Agarwal S, Arya V, Kumar R, Gupta UR, Agarwal SS. Prevention of homozygous beta thalassemia by premarital screening and prenatal diagnosis in India. Prenat Diagn 2009; 29: 83-8.
107. Silverstroni E, Bianco I. Screening for microcytemia in Italy: Analysis of data collected in the past 30 years. Am J Hum Genet 1975; 27: 198-212.
108. Mehta BC, Iyer PD, Gandhi SG, Ramnath SR, Patel JC. Diagnosis of heterozygous beta-thalassemia in a population with high prevalence of iron deficiency. Indian J Med Sci 1973; 27: 832-5.
109. Gomber S, Madan N. Validity of Nestroft in screening and diagnosis of β-thalassemia trait. J Trop Pediatr 1997; 43: 363-6.
110. Mamtani M, Das K, Jawahirani A, Rughwani V, Kulkarni H. Is NESTROFT sufficient for mass screening for beta-thalassaemia trait? J Med Screen 2007; 14: 169-73.
111. Saraya AK, Kumar R, Sehgal AK. Iron status in heterozygous beta-thalassemia: detection of coexisting iron deficiency by transferrin saturation and serum ferritin. Birth Defects Orig Artic Ser 1988; 23: 9-18.
112. Madan N, Sikka M, Sharma S, Rusia U. Frequency of coincident iron deficiency and beta-thalassaemia trait. J Clin Pathol 1996; 49: 1021.
113. Madan N, Sikka M, Sharma S, Rusia U. Phenotypic expression of hemoglobin A2 in β-thalassemia trait with iron deficiency. Ann Hematol 1998; 77: 93-6.
114. Menon SR, Khatkhatay MI, Dandekar SP, Patel ZM. Development and validation of an ELISA for hemoglobin-A2: a novel method for β-thalassemia screening in developing countries. J Immunoassay Immunochem 2004; 25: 135-46.
115. Ravindran MS, Patel ZM, Khatkhatay MI, Dandekar SP. Beta-thalassaemia carrier detection by ELISA: a simple screening strategy for developing countries. J Clin Lab Anal 2005; 19: 22-5.
116. Colah R, Thomas M, Mayekar P. Assessing the impact of screening and counselling high school children for β-thalassaemia in India. J Med Screen 2007; 14: 158.
117. Ahmed S, Saleem M, Modell B, Petrou M. Screening extended families for genetic hemoglobin disorders in Pakistan. N Engl J Med 2002; 347: 1162-8.
118. Cao A, Galanello R. Effect of consanguinity on screening of thalassemia. N Engl J Med 2002; 347: 1200-2.
119. Gorakshakar AC, Colah RB. Cascade screening for beta-thalassemia: A practical approach for identifying and counseling carriers in India. Indian J Community Med 2009; 34: 354-6.
120. Yagnik H. Post counseling follow up of thalassemia in high risk communities. Indian Pediatr 1997; 34: 1115-8.
121. Saxena A, Phadke SR. Feasibility of thalassaemia control by extended family screening in Indian context. J Health Popul Nutr 2002; 20: 31-5.
122. Indian Red Cross Society (IRCS), Gujarat State Branch. Annual Report 2009-2010. Ahmedabad: IRCS, Gujarat State Branch; 2010.
123. Colah R, Surve R, Wadia M, Solanki P, Mayekar P, Thomas M, et al. Carrier screening for beta-thalassemia during pregnancy in India: a 7-year evaluation. Genet Test 2008; 12: 181-5.
124. Mohanty D, Colah R, Gorakshakar. Jai Vigyan S & T Mission Project on community control of thalassemia syndromes - Awareness, screening, genetic counseling and prevention. New Delhi: Indian Council of Medical Research; 2008.
125. Muralitharan S, Srivastava A, Shaji RV, Mathai M, Srivastava VM, Dennison D, et al. Prenatal diagnosis of beta-thalassaemia mutations using the reverse dot blot technique. Natl Med J India 1996; 9: 70-1.
126. Saxena R, Jain PK, Thomas E, Verma IC. Prenatal diagnosis of beta-thalassaemia: experience in a developing country. Prenat Diagn 1998; 18: 1-7.
127. Thakur C, Vaz F, Banerjee M, Kapadia C, Natrajan PG, Yagnik H, et al. Prenatal diagnosis of beta-thalassaemia and other haemoglobinopathies in India. Prenat Diagn 2000; 20:194-201.
128. Garewal G, Das R, Ahluwalia J, Marwaha RK, Varma S. Nucleotide -88 (C-T) promoter mutation is a common beta-thalassemia mutation in the Jat Sikhs of Punjab, India. Am J Hematol 2005; 79: 252-6.
129. Garewal G, Das R, Awasthi A, Ahluwalia J, Marwaha RK. The clinical significance of the spectrum of interactions of CAP+1 (A-->C), a silent beta-globin gene mutation, with other beta-thalassemia mutations and globin gene modifiers in north Indians. Eur J Haematol 2007; 79: 417-21.
130. Newton CR, Graham A, Heptinstall LE, Powell SJ, Summers C, Kalsheker N, et al. Analysis of any point mutation in DNA - the amplification refractory mutation system (ARMS). Nucleic Acids Res 1989; 17: 2503-16.
131. Wadia MR, Phanasgaokar SP, Nadkarni AH, Surve RR, Gorakshakar AC, Colah RB, et al. Usefulness of automated chromatography for rapid fetal blood analysis for second trimester prenatal diagnosis of beta-thalassemia. Prenat Diagn 2002; 22: 153-7.
132. Rao S, Saxena R, Deka D, Kabra M. Use of HbA estimation by CE-HPLC for prenatal diagnosis of beta-thalassemia; experience from a tertiary care centre in north India: a brief report. Hematology 2009; 14: 122-4.
133. http://www.who.int/healthinfo/global_burden_disease/en/, accessed on October 4, 2011.
134. http://data.worldbank.org/about/country-classifications, accessed on October 4, 2011.
135. Weatherall DJ. Keynote address: The challenge of thalassemia for the developing countries. Ann N Y Acad Sci 2005; 1054: 11-7.